Infections due to Clostridium difficile, MRSA or VRE: Discharge Abstract Database
Discharge Abstract Database (DAD) Codes included in this clinical category:
B18: Infections due to Clostridium difficile, MRSA or VRE
Concept |
Bacterial infections identified during a hospital stay due to Clostridium difficile (C. difficile), methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant enterococci (VRE). |
C. difficile |
|
Selection criteria |
|
A04.7 |
Identified as diagnosis type (2) |
Exclusions |
|
MRSA |
|
Selection criteria |
|
A04.10 |
Identified as diagnosis type (2) AND U82.1 as diagnosis type (1) or (2) in the same diagnosis cluster OR Identified as diagnosis type (3) AND U82.1 as diagnosis type (1) or (2) AND T80.2, T81.4, T82.6, T82.7–, T83.5, T83.6, T84.5–, T84.6–, T84.7, T85.7 or T88.0 as diagnosis type (2) AND Y60–Y84 in the same diagnosis cluster OR Identified as diagnosis type (3) AND U82.1 as diagnosis type (1) or (2) AND O03.0, O03.5, O04.0, O04.5, O05.0, O05.5, O07.3 or O08.0– as diagnosis type (2) in the same diagnosis cluster OR Identified as diagnosis type (3) AND U82.1 as diagnosis type (1) or (2) AND O98.502 or O98.802 as diagnosis type (M), (1), (2), (W), (X) or (Y) in the same diagnosis cluster |
A49.0 |
Identified as diagnosis type (2) AND U82.1 as diagnosis type (1) or (2) in the same diagnosis cluster |
B95.6 |
Identified as diagnosis type (3) AND U82.1 as diagnosis type (1) or (2) AND a site of infection code* as diagnosis type (2) in the same diagnosis cluster |
Exclusions |
Abstracts with a length of stay less than 2 days |
VRE |
|
Selection Criteria |
|
A41.80* |
Identified as diagnosis type (2) AND U83.0 as diagnosis type (1) or (2) in the same diagnosis cluster OR Identified as diagnosis type (3) AND U83.0 as diagnosis type (1) or (2) AND T80.2, T81.4, T82.6, T82.7–, T83.5, T83.6, T84.5–, T84.6–, T84.7, T85.7 or T88.0 as diagnosis type (2) AND Y60–Y84 in the same diagnosis cluster OR Identified as diagnosis type (3) AND U83.0 as diagnosis type (1) or (2) AND O03.0, O03.5, O04.0, O04.5, O05.0, O05.5, O07.3 or O08.0– as diagnosis type (2) in the same diagnosis cluster OR Identified as diagnosis type (3) AND U83.0 as diagnosis type (1) or (2) AND O98.502 or O98.802 as diagnosis type (M), (1), (2), (W), (X) or (Y) in the same diagnosis cluster |
B96.81* |
Identified as diagnosis type (3) AND U83.0 as diagnosis type (1) or (2) AND a site of infection code* as diagnosis type (2) in the same diagnosis cluster |
* Before 2018-2019 data |
|
Exclusions |
Abstracts with a length of stay less than 2 days |
Codes |
Code descriptions |
A04.7 |
Enterocolitis due to Clostridium difficile |
A41.0 |
Sepsis due to Staphylococcus aureus |
A41.80 |
Sepsis due to Enterococcus |
B95.6 |
Staphylococcus aureus as the cause of diseases classified to other chapters |
B96.81 |
Enterococcus as the cause of diseases classified to other chapters |
A49.0 |
Staphylococcal infection, unspecified site |
J15.2 |
Pneumonia due to Staphylococcus |
G00.3 |
Staphylococcal meningitis |
L00 |
Staphylococcal scalded skin syndrome |
O03.0 |
Spontaneous abortion, incomplete, complicated by genital tract and pelvic infection |
O03.5 |
Spontaneous abortion, complete or unspecified, complicated by genital tract and pelvic infection |
O04.0 |
Medical abortion, incomplete, complicated by genital tract and pelvic infection |
O05.0 |
Other abortion, incomplete, complicated by genital tract and pelvic infection |
O05.5 |
Other abortion, complete or unspecified, complicated by genital tract and pelvic infection |
O07.3 |
Failed attempted abortion, complicated |
O08.0– |
Complication following abortion and ectopic and molar pregnancy; genital tract and pelvic infection |
O98.502 |
Other viral diseases complicating pregnancy, childbirth and the puerperium; delivered with mention of postpartum complication |
O98.802 |
Other maternal infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium; delivered with mention of postpartum complication |
T80.2 |
Infections following infusion, transfusion and therapeutic injection |
T81.4 |
Infection following a procedure, not elsewhere classified |
T82.6 |
Infection and inflammatory reaction due to cardiac valve prosthesis |
T82.7– |
Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts |
T83.5 |
Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
T83.6 |
Infection and inflammatory reaction due to prosthetic device, implant and graft in genital tract |
T84.5– |
Infection and inflammatory reaction due to internal joint prosthesis |
T84.6– |
Infection and inflammatory reaction due to internal fixation device (any site) |
T84.7 |
Infection and inflammatory reaction due to other internal orthopedic prosthetic devices, implants and grafts |
T85.7 |
Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts |
T88.0 |
Infection following immunization |
U82.1 |
Resistance to methicillin |
U83.0 |
Resistance to vancomycin |
Y60–Y84 |
Complications of medical or surgical care (refer to Appendix A of the Hospital Harm Indicator General Methodology Notes) |
*For the descriptions of site of infection codes, please see Appendix B of the Hospital Harm Indicator General Methodology Notes.